A Study to Evaluate Efficacy of Dotinurad and Febuxostat for the Treatment of Participants With Gout

NCT05007392 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

451

Enrollment

INDUSTRY

Sponsor class

Conditions

Gout

Interventions

DRUG: Dotinurad
DRUG: Febuxostat
OTHER: Dotinurad Matched Placebo
OTHER: Febuxostat Matched Placebo

Sponsor

Eisai Co., Ltd.